INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Caligan Partners LP's Holding History (CIK: 0001727492)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 1,293,510 Value ($000) $14,306 Avg Close — Range —